CBAY

Q: What is the price of CymaBay Therapeutics (CBAY) today?

The price of CymaBay Therapeutics (CBAY) today is $ 0.00, with return of 0% compared to the last year. The price of CymaBay Therapeutics (CBAY) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of CymaBay Therapeutics (CBAY) and international markets.

Q: When does CymaBay Therapeutics (CBAY) pay dividends?

CymaBay Therapeutics (CBAY) did not distribute dividends in the last year.

Q: Is CymaBay Therapeutics (CBAY) worth it?

Currently, CymaBay Therapeutics (CBAY) is priced at $ 0.00, with a P/E of -34.99%, representing a deviation of -2,018% from its historical average P/E. In the last year, the stock showed a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy CymaBay Therapeutics (CBAY) stock?

Investing in stocks of CymaBay Therapeutics (CBAY) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of CymaBay Therapeutics (CBAY) yield today?

The yield of CymaBay Therapeutics (CBAY) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of CymaBay Therapeutics (CBAY) today, the total investment would be $ 0.00, based on the current price of $ 0.00.If past performance were to repeat, the return on your investment would be:In 1 year: $ 0.00In 5 years: $ 0.00In 10 years: $ 0.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

CymaBay Therapeutics Inc.

This asset is no longer available for investment.

View all assets

Price

$ -

return (12m)

0.00%

p/e

-34.99

p/bv

13.22

DIVIDEND YIELD

0.00%

CBAY price

CBAY

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment CBAY

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals CBAY

review the fundamentals of CymaBay Therapeutics shares

P/E

-34.99

Sector: -2.04 Industry: 0.41

P/S (PSR)

124.36

Sector: 1.88 Industry: 2.43

P/BV

13.22

Sector: 2.11 Industry: 2.30

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-25.41%

Sector: -25.47% Industry: -24.33%

ROE

-37.80%

Sector: -29.41% Industry: -29.69%

ROIC

-544.54%

Sector: -411.21% Industry: -75.87%

NET MARGIN

-100.00%

Sector: -28.27% Industry: -30.45%

GROSS MARGIN

100.00%

Sector: 44.66% Industry: 50.55%

OPERATING MARGIN

-100.00%

Sector: -23.29% Industry: -26.81%

EV/EBITDA

-41.12

Sector: -0.79 Industry: 0.98

EV/EBIT

-40.82

Sector: -2.18 Industry: -0.36

PRICE-TO-ASSETS

8.89

Sector: 1.13 Industry: 1.22

BVPS

2.46

Sector: 3.60 Industry: 4.74

EPS

-0.93

Sector: -0.89 Industry: -0.81

EQUITY-TO-ASSETS RATIO

0.67

Sector: 0.43 Industry: 0.45

LIABILITIES / ASSETS

0.67

Sector: 0.47 Industry: 0.51

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

3.20%

Sector: - Industry: -

Fundamentals CBAY

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	38.09	32.96	86.53%	0.71%	$ 786.02 B	31.66%
ISRG	56.27	8.96	15.92%	0.00%	$ 160.69 B	28.38%
TMO	26.55	3.32	12.52%	0.36%	$ 177.98 B	15.05%
SNY	12.52	1.36	10.86%	4.73%	$ 114.19 B	18.68%
NVS	20.29	6.10	30.04%	4.71%	$ 283.76 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	24.24	2.27	9.38%	3.25%	$ 111.80 B	13.00%
CVS	50.34	1.18	2.35%	3.80%	$ 89.00 B	0.44%
GSK	14.19	5.07	35.71%	3.10%	$ 108.22 B	17.48%
BSX	35.40	0.00	0.00%	0.00%	$ 102.58 B	14.44%
TMDX	17.70	7.12	40.22%	0.00%	$ 3.37 B	31.43%
HCA	15.86	-38.82	-244.82%	0.61%	$ 107.58 B	8.97%
IDXX	42.16	27.82	65.99%	0.00%	$ 44.67 B	24.62%
RMD	21.66	5.09	23.51%	1.06%	$ 32.19 B	27.53%
DHR	35.51	2.44	6.88%	0.71%	$ 128.33 B	14.71%
INMD	9.00	1.24	13.73%	0.00%	$ 844.20 M	25.32%
PHG	24.55	1.98	8.06%	3.31%	$ 25.47 B	5.07%
FMS	11.18	0.75	6.75%	3.57%	$ 12.62 B	5.02%
SYK	38.64	5.59	14.48%	1.04%	$ 125.41 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

CBAY Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT CymaBay Therapeutics

CymaBay Therapeutics Inc.

Average Investor10 user rating

4.0 (2 people)

United States

38 years

Founded: 1988

2014

Time since IPO - 12 years

44

Employees

The Company CymaBay Therapeutics Inc. (United States), is listed on Nasdaq with a market value of $ 3.87 Billions, having an equity of $ 292.26 Millions.

With a total of 44 employees, the company is listed in the sector of Health and categorized in industry of Pharmaceutical Products.

In the last 12 months the Company had a revenue of $ 31.08 Millions, which generated a loss in the amount of $ -105.37 Millions.

As for its main indicators, the Company has a P/E ratio of -34.99, a P/BV ratio of 13.22 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker CBAY.

Market cap

$ 3.87 Billions

Net worth

$ 292.26 Millions

US$ 292,260,000.00

Assets

$ 434.69 Millions

US$ 434,690,000.00

Total Shares Outstanding

119.00 Millions

119,000,000

Average Daily Trading Volume

$ 4.45 Millions

US$ 4,451,324.78

Sector

Health

Industry

Pharmaceutical Products

CBAY

CBAY revenue and profits

Financial Results CBAY

DRAG THE FRAME TO SEE MORE DATA

CBAY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 73.49 20,99% (12M)

P/E

50.34

3.80%

ROE

2.35%

P/BV

1.18

CI - Cigna

$ 270.02 --14,47% (12M)

P/E

10.14

2.32%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 35.11 --43,31% (12M)

P/E

-2.36

0.00%

ROE

-33.28%

P/BV

0.79

HUM - Humana

$ 177.83 --28,58% (12M)

P/E

17.08

2.09%

ROE

6.70%

P/BV

1.14

HCA - HCA Healthcare

$ 471.84 43,24% (12M)

P/E

15.86

0.61%

ROE

-244.82%

P/BV

-38.82

LLY - Eli Lilly

$ 935.58 30,21% (12M)

P/E

38.09

0.71%

ROE

86.53%

P/BV

32.96

NVS - Novartis

$ 154.03 53,71% (12M)

P/E

20.29

4.71%

ROE

30.04%

P/BV

6.10